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Uropathogenic Escherichia coli (UPEC) are a com-
mon cause of urinary tract infections (UTIs) in hu-
mans. While the importance of natural killer (NK) cells
in innate immune protection against tumors and viral
infections is well documented, their role in defense
against bacterial infections is still emerging, and their
involvement in UPEC-mediated UTI is practically
unknown.Usingasystematicmutagenesis approach,
we found that UPEC adheres to NK cells primarily via
its type I fimbriae and employs its hemolysinA toxin to
kill NK cells. In the absence of hemolysinA, NK cells
directly respond to the bacteria and secrete the
cytokine TNF-a, which results in decreased bacterial
numbers in vitro and reduction of bacterial burden in
the infected bladders. Thus, NK cells control UPEC
via TNF-a production, which UPEC counteracts by
hemolysinA-mediatedkillingofNKcells, representing
a previously unrecognized host defense andmicrobi-
al counterattack mechanism in the context of UTI.
INTRODUCTION
E. coli colonize the gastrointestinal tract of human infants within
a few hours after birth (Kaper et al., 2004). This commensal bac-
terium rarely causes disease except in immunocompromised
hosts (Kaper et al., 2004). However, there are several highly
adapted pathogenic E. coli strains that cause a broad spectrum
of diseases, including enteric disease, sepsis/meningitis, and
UTI (Emody et al., 2003; Johnson, 1991). UPEC is responsible
for approximately 80%–90% of community-acquired UTI cases
(Sivick et al., 2010; Ulett et al., 2013), and around 50% of all
women and 12% of men will experience at least one episode
of a clinically significant infection during their lifetime (Sivick664 Cell Host & Microbe 14, 664–674, December 11, 2013 ª2013 Elset al., 2010). UPEC utilize virulence factors that are encoded
on pathogenicity islands (Ulett et al., 2013) to infect an immuno-
competent host by colonizing the periurethral area and subse-
quently ascend through the urethra to the bladder (Kucheria
et al., 2005). In the bladder, uroepithelial cells are the early sen-
sors of microbial challenge (Ragnarsdo´ttir et al., 2011). Neutro-
phils are the first and most-abundant cell type to migrate to the
bladder in the event of UTI, and they constitute a crucial limiting
factor for bacterial growth in the urinary tract (Haraoka et al.,
1999). In addition, other immune cells have also been implicated
in host defense against UTI (Engel et al., 2006; Jones-Carson
et al., 1999). However, it is practically unknownwhether NK cells,
which are critical players in the innate immune response, are pre-
sent in the bladder or involved in UTIs.
NK cells are lymphocytes which make up to 15% of all periph-
eral blood lymphocytes (Seidel et al., 2012). They are best known
for their ability to kill virally infected and transformed cells and for
secreting cytokines, specifically TNF-a and IFN-g (Jewett et al.,
1996). The NK cell activity is regulated through a balance of
signals derived from inhibitory and activating receptors (Koch
et al., 2013). Their ligands are numerous and can be stress
induced, tumor derived, pathogen derived, and even self-ligands
(Seidel et al., 2012). While the importance of NK cells in innate
immune protection against tumors or viral infections is well
documented (Koch et al., 2013), their ability to directly recognize
bacteria is less well defined. In this regard, we have previously
shown that NK cells are able to directly recognize Fusobacterium
nucleatum through their killer receptor NKp46 and that this inter-
action exacerbated periodontal disease (Chaushu et al., 2012).
In this study we show in vitro that strains of UPEC adhere to
human and murine NK cells primarily through their type I fimbria
and kill NK cells via their hemolysinA toxin. We demonstrate
in vivo that NK cells accumulate in the bladder during UTI and
that in the absence of hemolysinA the interaction between NK
cells and E. coli leads to TNF-a secretion, which attenuates the
infection. In contrast, pathogenic UPEC strains that express
hemolysinA evade this NK cell control by killing the NK cells.evier Inc.
Figure 1. UPEC Kill Human NK Cells
(A) Flow cytometry analysis of various GFP-expressing strains of E. coli (indicated above the quadrants) incubated with primary human NK cells and stained with
PI (y axis). The bacterium to NK ratio was 30:1, and incubations were performed for 3 hr either at 4C (upper quadrants) or at 37C (lower quadrants). The
percentages of NK cells in each quadrant are indicated.
(B) Forward and side scatter analysis of NK cells incubated with or without UPEC CFT073, at 4C or at 37C (indicated inside the quadrants). Gate 1 shows live
human NK cells, and gate 2 shows the nonviable ones.
(C) Ratios 3100 of viable NK cells present in gate 1 following 3 hr of incubation with the indicated bacteria at 37C were divided by the number of NK cells
incubated with the same bacteria for 3 hr at 4C.
(D) Percentages of PI-positive NK cells present in gate 2 following 3 hr incubation at 37C with the various GFP expression E. coli strains, indicated in the x axis.
(E) Confocal microscopy of PI-stained human NK cells incubated with different GFP expressing E. coli strains for 3 hr at 37C. The different bacteria are indicated
by green staining, DAPI is in blue, and PI is in red. Magnification 31,800.
(F) Confocal microscopy, SEM, and TEM of human NK cells incubated with UPEC CFT073 for 3 hr at 37C. The bacterium to NK cells ratio was 30:1. The
bacteria seen in the confocal microscopy are indicated by green staining, PI is in blue, and the anti-CD56 staining is in red. The TEM and SEM pictures are
marked.
(G) Shown are percentages of PI-positive NK cells following incubation of NK cells at 37C with the indicated bacteria at various time points (indicated in the
x axis). The bacterium to NK cells ratio was 30:1.
(H)Percentagesof PI-positiveNKcells following 3hr incubationat 37Cwith the indicatedE. coli strains at several bacteria toNKcells ratios (indicated at the xaxis).
Figures show one representative experiment out of at least three independent experiments performed and an average ±SD of duplicate in (C), (D), (G), and (H). For
(C) and (D), *p <0.00001 forUPECCFT073 versus all other bacteria. For (G) and (H) *p <0.01 for UTI536 versus all other bacteria. 25922 represent ATCC25922. See
also Table S1 and Figure S1.
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UPEC Kill NK Cells to Establish UTIRESULTS
Strains of UPEC Kill Human NK Cells
To test whether bacteria are directly recognized by NK cells, we
incubated several bacterial strains (Figure S1 available online),
including GFP-expressing E. coli strains (Figure 1) with humanCell Host &NK cells. The incubation was performed either at 4C or at
37C. NK cells were analyzed by flow cytometry for GFP (indic-
ative of bacterial binding) and for PI (to detect dead cells). As
can be seen in Figure 1A, at 4C (upper dot plots) we observed
enteric (EPEC) and urinary pathogenic E. coli strains: UPEC
SR71 and UPEC CFT073 (cystitis and pyelonephritis isolates,Microbe 14, 664–674, December 11, 2013 ª2013 Elsevier Inc. 665
Figure 2. UPEC CFT073 Preferentially Kills NK Cells
(A) Adhesion of UPEC CFT073 to human NK and T cells was determined by
percentages of GFP-positive cells following 3 hr incubation at 4C.
(B) Killing of human NK and T cells following 3 hr incubation at 37Cwith UPEC
CFT073 was determined by the percentages of cells stained with PI. Figures
show a representative of three independent experiments, and an average ±SD
of duplicate is presented. *p < 0.0005.
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bacteria were incubated with the human NK cells at 37C, they
interacted with higher percentages of NK cells (lower dot plots,
Figure 1A), and to our surprise a substantial (around 72%, upper
quadrants) PI staining (indicative of cell death) was observed
with UPEC CFT073 (Figure 1A). This pattern of PI staining was
not seen with XL1 or with the UPEC SR71 strain, nor was it
observed with EPEC or with other bacterial species tested
(Figure S1).
The PI staining observed with the UPEC CFT073 bacterium
was accompanied by changes in themorphology of the NK cells.
As can be seen in Figure 1B, at 37C, in the presence of UPEC
CFT073 the NK cells appeared smaller and were mostly present
in gate 2 (the cells in this gate were stained positive for PI). In
contrast, when NK cells were incubated with UPEC CFT073 at
4C, a normal NK cell morphology was evident, and most cells
were present in gate 1 (the NK cells in this gate are mainly PI
negative). Furthermore, at 4C, the NK cell population in gate 1
was more or less equivalent in size to the population of NK cells
observed when UPEC CFT073 is absent (Figure 1B). Figures 1C
and 1D summarize and quantify these observations. As can be
seen, little or no changes were observed when bacteria other
than UPEC CFT073 were used. To further corroborate our
findings, we used confocal microscopy, and as can be seen in
Figure 1E, nearly all NK cells were stained positive for PI when
incubated at 37C for 3 hr with UPEC CFT073. The bacteria,
on the other hand, remained PI negative when incubated with
the NK cells either at 37C (Figure 1E) or at 4C (data not shown),
suggesting that the bacteria are not killed by the NK cells. To
determine whether UPECCFT073 invades the NK cells, we incu-
bated the NK cells for 3 hr at 37C with the GFP-labeled UPEC
CFT073 bacterium and stained the human NK cells with the
anti-CD56 mAbs that primarily stain the NK cell membrane (Fig-
ure 1F, left). As can be seen, the UPEC CFT073 bacterium does
not seemed to penetrate into the dead humanNK cells. Scanning
electron microscopy (SEM), (Figure 1F, right) and transmission
electron microscopy (TEM) (Figure 1F, bottom) experiments
indeed demonstrated that the bacteria are not found inside the
NK cells.666 Cell Host & Microbe 14, 664–674, December 11, 2013 ª2013 ElsTo investigate whether (1) NK cell killing is a phenomenon
unique to the UPEC CFT073 strain only or (2) NK cell killing
relates to the type of pathology caused by different isolates
(cystitis versus pyelonephritis), we incubated additional strains
of urinary pathogenic E. coli (UTI536, ATCC 25922, and UTI89)
with human NK cells. The various E. coli strains were incubated
at various time points (Figure 1G) and at varying ratios of bacteria
to NK cells (Figure 1H). As can be seen in Figure 1G, even
following 4 hr of incubation with SR71 and XL1 NK cell death
was not detected. At longer time points the bacteria grow to
such an extent that their overabundance caused nonspecific
NK and bacteria death. Following 4 hr of incubation of CFT073,
UTI536, UTI89, and ATCC 25922 with the NK cells, nearly
100% NK cell death was observed (Figure 1G). The UTI536 bac-
terium was exceptionally efficient at killing human NK cells, as
around 60% of the NK cells were killed following 2 hr incubation
with this strain, as opposed to around 30% killing observed with
the other UPEC ‘‘killer’’ strains (Figure 1G). When repeating the
experiments for 3 hr at various bacteria to NK cells ratios,
UTI536 was again extremely efficient in killing the NK cells (Fig-
ure 1H). To test whether the UPEC-mediated killing is specific
to NK cells, we incubated primary T and NK cells with the
GFP-labeled UPEC CFT073 at 4C and at 37C (Figure 2). As
can be seen, while the bacterium binds both T and NK cells at
equivalent levels (Figure 2A), the T cells (Figure 2B) were almost
completely resistant to the UPECCFT073-mediated killing, while
the NK cells were highly sensitive (Figure 2B).
UPEC CFT073 Adheres to NK Cells via Type I Fimbriae
and Kills NK Cells via HemolysinA
To identify the component(s) by which UPEC adheres and kill
the NK cells, we generated transposon-based insertion-inacti-
vation mutant library in GFP-expressing UPEC CFT073 bacte-
rium. To identify the genes involved in UPEC CFT073 adhesion,
we incubated the mutant bacteria at 4C, and to identify the
killing/lytic components, we incubated the mutants for 3 hr
with NK cells at 37C. More than 1,000 clones were screened.
Nine UPEC CFT073 mutants were found to be impaired in their
adhesion (Figure 3A), but not in NK cell killing (Figure 3B), and
three mutants were identified, having an intact adhesion ability
(Figure 3C) but impaired killing activity (Figure 3D). One irrele-
vant mutant, B5, is shown in Figure 3 and throughout the paper.
In eight of the nine UPEC CFT073 adhesion mutants, the trans-
poson was inserted in the operon encoding for the type I
fimbriae, or in type I fimbriae-associated genes (Figure 3E).
The gene disrupted in the ninth mutant was tRNA uridine (Fig-
ure 3E). Interestingly, none of these mutants completely lost
their adhesion potential, and as can be seen, even 50%
reduction in adhesion was still sufficient to kill NK cells after
3 hr of incubation at 37C (Figures 3A and 3B). The disrupted
genes of the three killing mutants were also identified (Figure 3E)
and were found to reside on the hlyA operon that encodes for
the hemolysinA toxin. Two mutants were found to be defective
both in adhesion to NK cells and in killing the NK cells (Figures
S2A and S2B, respectively). Sequencing of the disrupted genes
revealed that both are housekeeping genes (Figure S2C), which
are essential for bacterial growth (Figure S2D). The growth and
the biological properties of all other relevant mutants were
normal (Figure S2D).evier Inc.
Figure 3. Transposon-Based Mutagenesis
Identifies Type I Fimbriae and HemolysinA
(A) More than 1,000 GFP-expressing UPEC
CFT073 mutants were screened for adhesion to
primary human NK cells at 4C (A and C, deter-
mined by percentages of GFP-positive NK cells)
and for killing of human NK cells at 37C (B and D
determined by PI-positive NK cells). B5, an irrele-
vant mutant of UPEC CFT073 was used as a
control. Data are representative of at least three
independent analyses of the relevant mutants.
Data are represented as mean ± SEM. *p < 0.001.
(E) Table summarizing the transposon location in
the disrupted genes of relevant mutants. The
adhesion mutants are in white, the hemolysinA
mutants are in dark gray, and the irrelevant mutant
B5 (bottom) is in light gray. See also Figure S2.
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UPEC Kill NK Cells to Establish UTIIncreased Adhesion through the Type I Fimbriae Leads
to Increased Killing of NK Cells
The expression of the fimbriae is regulated by an invertible element
which alternates between an ‘‘on’’ and an ‘‘off’’ orientation (Kaper
et al., 2004; Ulett et al., 2013; Hannan et al., 2008). To further
validate our findings, two additional GFP-expressing mutants of
UPEC CFT073 bacteria were tested: one in which the fimbriae
has been locked in an ‘‘ON’’ orientation (Fim on) and another that
was locked in an ‘‘OFF’’ orientation (Fim off). In addition, we tested
whether P-fimbria (Mobley et al., 1993) might be involved in the
residual adhesion toNKcellsbyusingaGFP-expressingP-fimbriae
mutant (PAP, alsoknownasUPEC76).Ascanbeseen (Figure4A),
whentheFimoffbacteriumwasused, theadhesionwas reducedby
around 50%, and the absence of the P-fimbriae had no effect. The
binding of the Fimonmutant wasmuch stronger than all other bac-
teria, andaround85%of theNKcellswereboundby thebacterium.
The increased adhesion observed with the Fim on also led to
increased killing of NK cells. As can be seen in Figure 4B, at a ra-
tio of 30:1, at 1 hr following incubation of the Fim on bacterium
with the NK cells around 30% killing was observed, whereas
practically no killing was detected with all other bacteria.
Following 4 hr of incubation, around 100% killing of NK cells
was detectedwith all bacteria, except with the Fim off bacterium,
in which killing of the NK cells did not exceed 70%. Regarding
varying the bacteria:NK cell ratios, already at the 7.5:1 ratio the
killing of NK cells by the Fim on bacterium was very efficient
compared to other bacteria tested (Figure 4C). At the 30:1 ratio,
between 80%–90%of the NK cells were killed, depending on the
bacteria used; however, as above (Figure 4B), the killing of NK
cells by the Fim off bacterium did not exceed 70% (Figure 4C).
The Extent of HemolysinA Activity Determines the
Efficiency of NK Cell Killing
HemolysinA is a cytolytic pore-forming toxin which contributes
to tissue injury and erythrocyte hemolysis (Cavalieri et al.,Cell Host & Microbe 14, 664–674, D1984; Gadeberg et al., 1983). We there-
fore next investigatedwhether all bacteria
that killed the NK cells are able to cause
erythrocyte hemolysis. As can be seen
in Figure 5A, a clear zone in a blood
agar plate was evident with all ‘‘NK killer’’bacteria (Figure 1). In contrast, SR71 and XL1 did not perform
hemolysis (Figure 5A and data not shown, respectively) and
indeed lacks the hlyA gene (Totsika et al., 2009).
Type 1 fimbriae operon resides on a pathogenicity island along
with hemolysinA and is a frequent spot for insertional mutations
(Hannan et al., 2008). To confirm that the increased killing seen
with the Fim onmutant (Figures 4B and 4C) resulted from the bet-
ter adhesion properties of the mutant and to test whether the
higher killing seen in UTI536 (Figures 1G and 1H) might be
because this strain expresses two copies of the hemolysinA
operon (Wiles et al., 2008), quantified hemolysis on sheep red
blood cells (RBCs) was performed. As can be seen in Figure 5B,
the hemolysis levels of all bacteria tested were equivalent, and
the hemolysis induced by UTI536 was significantly higher.
To directly demonstrate that hemolysinA is responsible for the
human NK cell killing, we restored the hemolysis phenotype in
the hemolysinA mutant bacteria by transforming them with a
plasmid harboring the entire UPEC CFT073 hemolysinA operon
(the complemented bacteria were designated C93C, D57C,
and E49C). As can be seen in Figure 5C, hemolysis was restored
in the complemented bacteria, and they also regained their abil-
ity to kill the NK cells, as determined by flow cytometry (Figures
5D and S3) and by confocal microscopy (Figure 5E).
NK Cells Accumulate in the Infected Bladder following
UPEC CFT073 Infection
To investigate the physiological relevance of our findings, we
initially isolated murine NK cells and incubated them with the
various UPEC strains and with the three hemolysinA mutants.
As can be seen, the murine NK cells were efficiently killed
by ‘‘killer’’ bacteria, while no killing was observed either with
the hemolysinA mutants (C93, D57, and E49) or with XL1 and
SR71 bacteria (Figure 6A). Interestingly, mouse T cells, as
opposed to human T cells (Figure 2), were also quite efficiently
killed by all ‘‘killer’’ bacteria (data not shown).ecember 11, 2013 ª2013 Elsevier Inc. 667
Figure 4. Increased Type I Fimbriae-Medi-
ated Attachment Leads to an Increase in
Killing of Human NK Cells
(A) Percentages of binding of human NK cells
following 3 hr of incubation with GFP-expressing
bacteria indicated in the x axis. Binding was per-
formed at 4C and was calculated by the per-
centages of GFP-positive NK cells. *p < 0.0001 for
Fim on versus all other bacteria, **p < 0.01 for B5
and PAP versus A15, D33, and Fim off.
(B and C) Killing of human NK cells at 37C
following incubation with the GFP-labeled bacte-
ria, indicated in the legend, at several time points
(B) and at various bacteria to NK cells (E:T) ratios
(C). The percentages of NK cell killing by the
various bacteria were determined by PI staining.
Data are a representative of three independent
experiments and an average ± SD of duplicate is
shown. For (B) and (C), *p < 0.001 for Fim on
bacteria versus all other bacteria.
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UPEC Kill NK Cells to Establish UTIWe next tested whether murine NK cells are present in the
bladder prior and following UPEC CFT073 infection. For this, we
used the Ncr1gfp/+ mice that we generated, in which NK cells
are labeled with GFP and can easily be detected (Gazit et al.,
2006). UPEC CFT073 or the hemolysinA mutant C93 bacteria
were injected through catheters inserted into the bladders of 6-
to 8-week-old C57BL/6 Ncr1gfp/+ female mice, and NK cells
were counted in the bladder prior and following bacterial inocula-
tion.Weused theC93bacteriumhere and inmost of following ex-
periments because this mutant was disrupted in the structural
hlyA gene itself. The NK cell accumulation in the bladder was
monitored for 6 consecutive days post-UTI induction, by harvest-
ing the bladders and by counting the GFP-positive NK cells using
flow cytometry. In the absence of bacterial infection, NK cells
were hardly detected in the bladder; however, following bacterial
inoculation, NK cells accumulated in the bladder (Figure 6B), and
significantlymoreNK cells were observed inmice inoculatedwith
the hemolysinA mutant bacterium C93 as compared to the wild-
type bacterium (Figure 6B). The highest number of NK cells in
the bladder was observed on day 2 following UTI induction (Fig-
ure 6B). At later time points, the NK cells gradually disappeared
and were practically undetectable on day 5 postinfection (data
not shown). Cryosections from bladders were also obtained at
day 2 post-UTI induction, andNKcells in the bladderwere viewed
usingconfocalmicroscopy (Figure6C). In agreementwith theflow
cytometry experiments (Figure 6B), very few or no NK cells were
detected in the PBS-injected bladders, and the highest number
of NK cells was observed following inoculation with the hemoly-
sinA C93 mutant (Figure 6C, depicting a piece of the bladders’668 Cell Host & Microbe 14, 664–674, December 11, 2013 ª2013 Elsevier Inc.uroepithelial cells). Figure S4 illustrates
that following UPEC infection the NK cells
are found mainly in the uroepithelial cells,
especially in the mesenchymal area.
NK Cells Attenuate UTI through
TNF-a
NK cells do not kill the bacteria directly,
as incubation of NK cells with the wild-type UPEC CFT073 bacterium (Figure 1E) and with the hemoly-
sinA mutants (Figure 5E) did not result in PI staining of the
bacteria. Furthermore, no decrease in bacterial viability was
detected following incubation of the various bacteria with NK
cells (Figure S5). To investigate whether NK cells will produce
cytokines upon their direct interaction with the bacteria, we incu-
bated mouse NK cells with all wild-type bacteria used in this
work and determined the TNF-a concentrations in the superna-
tants. NK cells incubated with bacteria lacking the hemolysinA
toxin such as XL1 and SR71, secreted high levels of TNF-a
(Figure 7A), while the amount of TNF-a secreted from NK cells
incubated with the hemolytic UPEC strains was greatly reduced
(Figure 7A). This is due to NK cell killing by all of the hemolytic
UPEC strains (verified by PI staining at the end of the ELISA
assays, data not shown). Similar results were obtained with the
complemented hemolysinA bacteria and little secretion of TNF-
a was noted (data not shown).
To identify the NK cell receptor mediating the TNF-a secretion,
we initially investigated whether the two major murine NK-acti-
vating receptors, NKG2D andNcr1, are able to directly recognize
the bacteria. To this end, we used Ncr1-Ig and NKG2D-Ig fusion
proteins, and as can be seen in Figure 7B, all the bacteria tested
were not stained by the fusion proteins. In contrast, the murine
thymoma PD1.6 cells previously shown to express ligand for
Ncr1 (Halfteck et al., 2009) were recognized by both Ncr1-Ig
and NKG2D-Ig, whereas the Ncr1-ligand-negative YAC-1 cells
(Gazit et al., 2006) were recognized by NKG2D-Ig only (Fig-
ure 7B). It was previously shown that UPEC bacteria directly acti-
vate NK cells, leading to the secretion of TNF-a via TLR-4 (Mian
Figure 5. Hemolytic Bacteria Kill NK Cells
(A) Hemolysis of sheep RBCs was mediated by CFT073, ATCC 25922, UTI89, UTI536, and SR71 UPEC strains streaked on blood agar plates.
(B) Quantification of sheep RBCs hemolysis (represented in the y axis by O.D) induced by UPEC CFT073, the Fim on and Fim off mutants, and the UPEC UTI536
strains. RBCs treated with 1% triton were used as a positive control, and treatment with RPMI (phenol red minus) was used as a negative control. *p < 0.01 for
UTI536 and 1% triton versus all other bacteria.
(C) Hemolysis was mediated by the hemolysinA mutants (C93, D57, and E49, upper panels) and by the complemented hemolysinA bacteria (C93C, D57C, and
E49C, lower panels).
(D and E) Killing of NK cells by wild-type UPEC CFT073 bacterium, by the hemolysinA mutants (C93, D57, and E49) and by the complemented bacteria (C93C,
D57C, and E49C) at 37C, determined either by flow cytometry (D) or by using confocal microscopy (E). One of three (A, C, and E) or four (B and D) independent
experiments is shown. An average ±SD of duplicate is shown in (B) and (D). In (D), *p < 0.0001 for UPECCFT073 and E49C, D57C, and C93C versus E49, D57, and
C93. See also Figure S3.
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secretion, we incubated the irrelevant mutant B5 and the hemo-
lysinAmutant C93 bacteria with murine NK cells. The C93 bacte-
riumwas incubatedwith NK cells that were pretreated or not with
blocking anti-TLR-4 mAb. As can be seen, incubation of the NK
cells with C93 led to substantial TNF-a secretion which was
partially reduced by the anti-TLR-4 mAb (Figure 7C), suggesting
that TLR-4 is involved in the TNF-a secretion following the direct
interaction with the bacteria.
To investigate the importance of NK cells and TNF-a in vivo,
we initially performed calibration experiments in which bacterial
loads were evaluated in the bladders, kidneys, and blood over
6 days following bacterial inoculation, with or without depletion
of NK cells using the anti-NK1.1 mAb. The efficiency of the
anti-NK1.1 mAb in depleting NK cells was monitored using the
Ncr1gfp/+ mice that we have generated (Gazit et al., 2006). As
can be seen in Figure 7D, NK cells were present in the blood
and kidney, but not in the bladder, even prior to the bacteria inoc-Cell Host &ulation. Upon bacterial injection, the NK cell numbers were
reduced in the blood and concomitantly increased in the kidneys
and in the bladders (Figure 7D). Injection of anti-NK1.1 mAb led
to a near-complete reduction in the numbers of NK cells present
in the blood, kidneys, and bladders (Figure 7D). Following these
calibration experiments, we investigated the role played by NK
cells and TNF-a in UTI. Three groups of mice were catheterized:
group 1 was pretreated with anti NK1.1 antibody, 1 day prior to
the inoculation of the bacteria and 1 day following the catheter
inoculation; group 2 was pretreated with a soluble receptor for
TNF-a (Etanercept) on the day of bacterial inoculation and on
the following day; group 3 was left untreated (Figure 7E). The
three groups of mice were further divided into four subgroups:
one group received PBS, the second group received the wild-
type UPEC CFT073 bacterium, the third group was inoculated
with the irrelevant control mutant B5, and the fourth group was
inoculated with the hemolysinA mutant C93. The bladders and
kidneys were harvested on day 2, since according to ourMicrobe 14, 664–674, December 11, 2013 ª2013 Elsevier Inc. 669
Figure 6. NK Cells Accumulate in the
Bladder following UPEC CFT073 Infection
(A) Percentages of PI-positive murine NK cells
incubated at 37C for 3 hr with wild-type hemolytic
(CFT073, ATCC 25922, UTI89, UTI536) and
nonhemolytic (XL1, SR71) UPEC bacteria, with the
irrelevant mutant B5 or with the hemolysinA-defi-
cient mutants (C93, D57, and E49). *p < 0.005 for
CFT073, B5, ATCC 25922, UTI89, and UTI536
versus all other bacteria.
(B) Number of GFP-positive NK cells in the bladder
on day 1 and on day 2 following infection with
UPEC CFT073 or with the hemolysinA-deficient
C93 mutant. Injection of PBS was used as control
(five to eight mice were used in each group). *p <
0.005 for NK cells present in the bladders injected
with C93 on day 2 versus day 1 and versus day 2-
injected UPEC CFT073 bladders.
(C) Representative confocal microscopy images of
uroepithelial cells obtained from murine bladders
injected with PBS (top), with wild-type UPEC
CFT073 (middle), or with the hemolysinA-deficient
mutant C93 (bottom). NK cells are visualized by
GFP. Left panels depict merge staining of DAPI-
stained bladder cells with the GFP-labeled NK cells; right panels show the NK cells only. For (A) and (B), data are a representative of three independent ex-
periments, and an average ±SD of triplicate is shown. Slides for confocal microscopy were prepared from four to eight bladders of mice in each group and were
taken from two independent experiments on day 2 of UTI induction. 25922 stands for ATCC 25922. See also Figure S4.
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UPEC Kill NK Cells to Establish UTIcalibration experiments at this day the highest number of bacte-
ria were present in the bladder, along with the highest number of
NK cells. As can be seen in Figure 7F, the groups of mice that did
not undergo prior treatments and that were injected with UPEC
CFT073 or with the irrelevant mutant (B5) had significantly
more bacteria as compared to the C93-injected group. Impor-
tantly, in all of the NK cell-depleted groups (the NK cell depletion
was verified in the blood of each of the NK1.1-treated mice, prior
to the removal of the bladders) and in all of the Etanercept (TNF-a
blocker)-treated groups the bacterial load was similar to the un-
treated B5 and UPEC CFT073 groups (Figure 7F). This indicates
that NK cells and TNF-a play a significant role in attenuating/
controlling bacterial infection in the bladder in vivo. The UPEC
CFT073 bacterium or the mutant C93 bacterium could hardly
be detected in the kidneys, irrespective of whether or not NK
cells were depleted or whether TNF-a was blocked (Figure 7G).
To demonstrate directly that NK cells are responsible for the
TNF-a secretion following bacterial inoculation, we took the
bladder extracts used to determine the bacterial loads in Fig-
ure 7F and measured the TNF-a concentrations. The untreated
bladders injected with the C93 mutant had the lowest CFU (Fig-
ure 7F), and accordingly the levels of TNF-a were the highest
(Figure 7H). In contrast, in the untreated mice injected with the
B5 mutant, bacterial loads were elevated (Figure 7F), while the
TNF-a levels were reduced by 50% (Figure 7H). When NK cells
were depleted, the TNF-a levels were equivalent to those
observed following B5 inoculation, indicating that in response
to UPEC CFT073 infection, in the absence of hemolysinA, NK
cells secrete TNF-a in vivo.
During acute cystitis, UPEC invade the bladder epithelial cells
in a regulated process, named ‘‘developmental cycle’’ (Jorgen-
sen and Seed, 2012), that includes bacterial adhesion, invasion,
the formation of intracellular bacterial communities (IBCs) and
the release from the tissue via exfoliation. Because NK cells670 Cell Host & Microbe 14, 664–674, December 11, 2013 ª2013 Elsare observed in significant numbers in the bladders only 1 day
following the infection (Figure 6B), we assumed that NK cells
are not involved in the initial UPEC adhesion and invasion to
the uroepithelial cells. We therefore investigated, using TEM,
whether IBC can be observed in bladders infected with the
C93 mutant bacterium (as the growth of this bacterium is NK
cell sensitive; Figure 7F). The experiments were performed on
day 2, at the peak of NK cell accumulation. As can be seen in Fig-
ure 7I, IBCs were observed in the infected bladders even
following C93 inoculation, demonstrating that NK cells probably
do not inhibit IBC formation.
DISCUSSION
We started this research by noticing that UPEC CFT073 adheres
to NK cells and that binding of this bacterium led to killing of the
NK cells. The killing was not dependent on the type of urinary
tract infection, i.e., cystitis or pyelonephritis, but rather it
occurred when the bacteria expressed the hemolysinA protein.
The importance of these findings is highlighted by the fact that
UPEC strains are the most common etiological agents respon-
sible for uncomplicated UTI among otherwise healthy women
(Ulett et al., 2013). Mutant screening performed at 4C identified
nine mutants defective in adhesion to NK cells. Interestingly,
eight of the nine adhesion mutants were defective either in the
type I fimbriae genes or in type I fimbriae-related genes. Type I
fimbriae produced by more than 80% of all UPEC strains is
required for bacterial attachment to mannose residues of the
glycoprotein receptor uroplakin Ia on the surface of urinary
epithelium cells as well as for bacterial invasion and persistence
in target cells (Bouckaert et al., 2006).
After screening more than 1,000 bacterial mutants, we did not
find mutants which were defective in the other adhesions used
by UPEC to adhere to the uroepithelium such as P (Pap), F1C,evier Inc.
Figure 7. NK Cells Secrete TNF-a to Protect against UTI
(A) ELISA assays for TNF-a secretion (concentration represented as picogram/ml, pg/ml) from NK cells following 5 hr of incubation with the hemolytic (CFT073,
ATCC 25922, UTI89, UTI536) and nonhemolytic (XL1, SR71) UPEC bacteria at 37C. *p < 0.005 for XL1 versus all other hemolytic bacteria. Data are represented
as mean ± SEM. **p < 0.01 for SR71 versus all other hemolytic bacteria.
(B) FACS staining of UPECCFT073, the hemolysinA-deficient mutant C93, the irrelevant mutant B5, PD1.6 and YAC-1 cells with NCR1-Ig, and with the NKG2D-Ig
fusion proteins (staining is indicated by the black empty histograms). The gray-filled histogram represents staining with control Ig-fusion protein.
(C) ELISA assays for TNF-a secretion frommurine NK cells following 5 hr of incubationwith the irrelevant mutant B5 and the hemolysinA-deficient mutant C93. NK
cells incubated with the C93 bacteriumwere coincubated with or without blocking anti-TLR-4mAb. Data are represented asmean ± SEM. *p < 0.01 for C93 in the
absence of anti-TLR-4 mAb versus C93 in the presence of anti-TLR-4 mAb.
(D) Numbers of GFP-positive NK cells in the blood, kidneys, and bladders of mice treated with sterile PBS only or injected with the hemolysinA-deficient mutant
C93with or without NK cell depletion using anti-NK1.1mAb. *p < 0.01 formice injectedwith the bacteria versus no bacteria. Data are represented asmean ± SEM.
**p < 0.0001 for NK1.1-treated mice versus all other mice. ***p < 0.001 for bacteria in the bladders following UTI versus no bacteria or versus NK cell depletion.
(E) Schematic representation of the in vivo experiment. The catheter in the figure indicates the day of UTI induction.
(F and G) Bacterial loads in the bladders (F) and kidneys (G) as determined by colony-forming units (CFU) on day 2 following bacterial injection. Mice were treated
with anti-NK1.1 (NK1.1), with Etanercept (TNF-a), or with PBS as described in (E) and infectedwith UPECCFT073, themutant B5, or the hemolysinA-deficient C93
mutant. Data are represented as mean ± SEM. *p < 0.05 for mice inoculated with C93 only versus all other injections.
(H) ELISA assays for the presence of TNF-a in the infected bladders derived from (F). Three to five bladders were obtained from each group. Data are represented
as mean ± SEM. **p < 0.01 for C93-injected treated mice versus all other mice.
(I) TEM was performed 2 days following C93 injections into the bladder. Data in (A)–(D) and (I) is a representative of two independent experiments. The data
presented in (F)–(H) is a summary of two independent experiments. See also Figure S5.
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UPEC Kill NK Cells to Establish UTIS, M, and Dr (Stapleton, 2005). Thus, we concluded that these
other adhesion molecules are probably not involved in the
UPEC CFT073 adhesion to NK cells. Interestingly, none of the
adhesionmutants presented a complete absence of attachment.
This may be explained either by the presence of another adhe-
sion protein, composed of several redundant subunits, or by a
nonreceptor-mediated binding of UPEC CFT073 to NK cells.
Nevertheless, the type I fimbriae play a significant role in bacte-Cell Host &rial adhesion to NK cells, and when a mutant in which the
fimbriae was locked in an ‘‘on’’ orientation was used, approxi-
mately 90% of the NK cells bound the bacteria, and this led to
a very efficient killing of the NK cells.
Three mutants were identified that were completely defective
in their NK killing ability, and all three mutants were disrupted in
different genes belonging to the hemolysin operon (hlyA, hlyC,
and hlyD). Importantly, hemolysinA is associated with humanMicrobe 14, 664–674, December 11, 2013 ª2013 Elsevier Inc. 671
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UTI (Gadeberg et al., 1983). Approximately half of UPEC strains
that cause upper UTIs (pyelonephritis) and about a third of those
that cause lower UTIs (cystitis) express hemolysinA. This is in
contrast to only about 10% of fecal isolates that express hemo-
lysinA. The hemolysinA protein is unique among E. coli toxins
because it is secreted across both membranes (Cavalieri et al.,
1984). The ability of the hemolysin toxin to be secreted via
outer-membrane vesicles (Balsalobre et al., 2006) may explain
why the adhesionmutants were still able to efficiently kill NK cells
andmay also explain why dead NK cells are seen in the presence
of UPEC CFT073, even when the bacteria are not directly
attached to them. Still, as mentioned above, for efficient killing
of NK cells bacterial adhesion to NK cells is required.
NK cells were particularly sensitive to the hemolysin-mediated
killing, whereas human T cells were almost completely resistant.
The reason for this hemolysinA-mediated hypersensitivity of NK
cells is unknown. Virtually nothing is known about the sensitivity
of lymphocytes to hemolysinA-mediated killing. A literary search
identified one paper, from 1983 (Gadeberg et al., 1983), which
presents data which supports our findings. The authors showed
that hemolysinA was toxic to monocytes and granulocytes, and
lymphocytes were relatively resistant, whereas NK cells, which
had been discovered less than a decade beforehand, were not
tested (Gadeberg et al., 1983). Indeed, we also observed that
neutrophils were efficiently killed by the hemolysinA-expressing
bacteria (data not shown).
It was previously shown that hemolysinA can trigger rapid
degradation of paxillin as well as other host proteins and that it
also causes serine proteases and caspase activation which pro-
mote apoptosis of the host cells (Dhakal and Mulvey, 2012). This
explains why, in addition to lysing erythrocytes and killing of NK
cells (shown here), hemolysinA is toxic to a range of host cells.
Interestingly, it was also shown (Dhakal andMulvey, 2012; Ko¨nig
et al., 1994) that in addition to tissue injury, hemolysinA can indi-
rectly disrupt various aspects of host cell signaling and suppress
cytokine (such as IL-6 and TNF-a) release from human lympho-
cytes/monocytes and basophils. Thus, hemolysinA impairs TNF-
a activity in numerous ways: by killing NK cells directly, as shown
here, and indirectly, by impairing host cell signaling as shown
previously.
To evaluate the role played by NK cells in UTI, we initially
established that NK cells are absent from the bladder when no
infection is present and that they accumulate in the bladder
upon UTI induction. Because the NK cell numbers decreased
in the blood following the bacterial inoculation, we suggest that
NK cells are recruited to the bladder and kidney, at least partially,
from the blood.
Mice are not the best model for studying UTI, as they abun-
dantly express TLR-11 in their bladder and kidneys, whereas
this TLR is absent in humans (Lauw et al., 2005; Zhang et al.,
2004). This leads to TLR-11-dependent bacterial clearance
(Zhang et al., 2004). Indeed, we observed that 5–6 days postin-
fection themice were free of bacteria, irrespective of whether NK
cells were present or absent and independently of the type of
injected bacteria. Nevertheless, despite the limitations of this
in vivo model, we were able to convincingly demonstrate that
NK cells are important for UTI attenuation in vivo. While no direct
killing of the bacteria was observed, we demonstrated both672 Cell Host & Microbe 14, 664–674, December 11, 2013 ª2013 Elsin vitro and in vivo that NK cells secrete large amounts of TNF-
a in response to nonhemolytic UPEC infection.Whenwe blocked
TLR-4, we observed a partial reduction in TNF-a secretion, sug-
gesting that TLR-4 partially participates in production of TNF-a
from NK cells following direct interaction with UPEC and that
another receptor(s) whose identity is currently unknown can
also sense UPEC and secrete TNF-a. Supporting these observa-
tions, it was shown that NK cells secrete TNF-a via TLR-4 in
response to stimulation via FimH and LPS of UPEC (Mian
et al., 2010). Finally, we also demonstrate that IBCs are still
observed in the bladders of mice infected with the NK-sensitive
strain C93. It will be interesting to thoroughly study in the future
whether and how NK cells affect the UPEC developmental cycle
in the uroepithelial cells.
In summary, we discovered a host defense and microbial
counterattack mechanism in which NK cells control UTI and
UPEC retaliates by killing the NK cells using hemolysinA.
EXPERIMENTAL PROCEDURES
Mice
All experiments were performed using 6- to 8-week-old C57BL/6 female mice.
The generation of the Ncr1gfp/+ mice was described previously (Gazit et al.,
2006). All experiments were performed in accordance with the guidelines of
the local ethics committee.
Cells, Plasmids, and Bacterial Strains
Primary human andmouseNK cells were isolated fromPBLs of various healthy
donors and various mice, respectively, using the human and mouse NK cell
isolation kits and the autoMACS instrument according the manufacturer in-
structions (Miltenyi Biotec). Some of the bacterial strains and the plasmids
used in this study are described in Figure S1 and in Tables S1A and S1B.
Creation of UPEC CFT073 Transposon Library, Mutant Screen,
Bacterial Adhesion, and Killing Assays
EZ::TnKan transposomes (Bahar et al., 2009) were purified from the pMODKan
plasmid according to manufacturer’s instructions and electroporated into the
UPEC CFT073 bacteria harboring the GFP pCM18 plasmid. Primary NK cells
(either human or mice) were washed twice with RPMI 1640 without antibiotics
and incubated with the various bacteria (mutants or wild-type) at various bac-
terial to NK cells ratios as indicated. Incubations were performed, for various
time points, as indicated, usually, for 3 hr, either at 4C to determine adhesion
or at 37C to determine NK cell killing, and cells were analyzed by flow
cytometry.
Determining the Transposon Location
Genomic DNA was purified from the selected clones (GenElute, Sigma) and
restricted with HpaI, MfeI, and NdeI (New England Biolabs) which do not
cleave within the inserted transposon. The resulting fragments were then
self-ligated (TaKaRa) and used as a template for inverse PCR (Herculase II,
Agilent) for amplification of the transposons’ flanking sequences. The gener-
ated sequences were blasted against the CFT073 genome to determine the
location of the insertion mutation.
Hemolysis and Hemolysis Quantification
Bacteria were streaked on blood agar plates supplemented with the appro-
priate antibiotic, and hemolysis was determined visually by a clear zone
around the colony. Colonies were viewed using a Zeiss stemi SVII microscope
at an30.6 magnification and photographed using Infinity I camera. Hemolysis
quantification was performed as described previously (Warawa et al., 1999).
In Vivo Assays and Determination of Bacterial Loads
Female mice 6–8 weeks of age were anesthetized with Ketamine and Xylazine
before catheter insertion and then infected with 108 bacteria in 50 ml of sterile
PBS. Tissue samples were homogenized using a Fastprep (MP Biomedicals,evier Inc.
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UPEC Kill NK Cells to Establish UTIUSA), serially diluted, and spread on Maconkey plates (Novamed, Israel).
Plates were incubated overnight, and colonies were enumerated.
Cytokine Secretion Assays
Various bacteria were incubated with murine NK cells at a ratio of 10:1 for 5 hr
at 37C, 5% CO2. Supernatants were collected, and TNF-a levels were deter-
mined using standard ELISA.
NK Cell Depletion and Etanercept Treatment
Mice were injected i.p with 100 mg anti-NK1.1 Ab (PK136) in 200 ml of sterile
PBS. ThemAb was injected 1 day prior to and 1 day after bacterial inoculation.
Sterile PBSwas injected as a control. Depletion was verified in all treatedmice,
prior to bladder removal. To block TNF-a, a soluble receptor (Etanercept) was
injected. Each mouse received 0.4 mg of Etanercept once a day, on the day of
catheterization, following bacterial inoculation and 1 day later.
Statistical Methods
For statistical significance, Student’s t test analysis was used. A statistical
test was considered significant (*) when p < 0.05. ANOVA was used to identify
significant group differences.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and one table and can be found
with this article at http://dx.doi.org/10.1016/j.chom.2013.11.004.
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